Clinical Trial Update: Patient-derived Organoids Drug Screen in Pancreatic Cancer [NA]

View source ↗

Summary

The study completed a patient-derived pancreatic tumor organoids drug-screen to evaluate potential drug responses.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma
• Pancreatic Cancer
• Pancreatic Neoplasms

Snippet

Sponsor: Prof. Dr. med. Dres. h.c. Jan Schmidt, MME | Conditions: Pancreas Cancer, Pancreas Neoplasm | NA | Status: COMPLETED